Drug Firm Apotex Seeks Valuation Over C$5 Billion in Canada IPO
Canadian drug manufacturer Apotex Health Corp. and its shareholders are looking to raise as much as C$1.15 billion (about $830 million) in an initial public offering, at a valuation that would mean a healthy profit for SK Capital Partners.
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.